Header cover image

Chinese Pharmaceuticals & Biotech Top Growth Stocks

Results

8

2 new
According to our Simply Wall St analysis these are the best growth companies.. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.

8 companies

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥13.0b

A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

688076

CN¥40.99

7D

-4.2%

1Y

-3.1%

Xiamen Amoytop Biotech

Market Cap: CN¥34.5b

Engages in research, development, production, and sale of recombinant protein drugs in China.

688278

CN¥84.74

7D

2.0%

1Y

57.5%

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥36.4b

Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases.

688192

CN¥79.18

7D

3.2%

1Y

121.3%

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥12.6b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

300181

CN¥18.14

7D

-4.8%

1Y

48.3%

Boji Medical TechnologyLtd

Market Cap: CN¥4.1b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

New

300404

CN¥10.82

7D

-0.6%

1Y

49.7%

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.6b

Shanghai Rightongene Biotechnology Co., Ltd.

688217

CN¥28.74

7D

-1.6%

1Y

107.7%

Shijiazhuang Yiling Pharmaceutical

Market Cap: CN¥27.4b

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

New

002603

CN¥16.39

7D

0.06%

1Y

8.0%

Nanjing King-Friend Biochemical PharmaceuticalLtd

Market Cap: CN¥18.6b

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

603707

CN¥11.54

7D

1.9%

1Y

-6.9%